Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | SHBG | P04278 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL105253 | 1.00 | — | — | |
| SCHEMBL304422 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53CYP3A4SHBG | |
| SCHEMBL3617591 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53CYP3A4SHBG | |
| SCHEMBL3627047 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53CYP3A4SHBG | |
| SCHEMBL3624140 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53CYP3A4SHBG | |
| SCHEMBL3619227 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53CYP3A4SHBG | |
| SCHEMBL103931 | 1.00 | — | — | |
| SCHEMBL3618893 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53CYP3A4SHBG | |
| SCHEMBL303088 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53CYP3A4SHBG | |
| SCHEMBL78474 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108698824-B | Process for preparing polymeric sulfur | 伊士曼化工公司 | 2022-08-16 | — | — | CN | claimed |
| US-20050027008-A1 | Cancer remedy comprising anthranilic acid derivatives as active ingredient | TEIJIN LIMITED | 2005-02-03 | — | — | US | claimed |
| US-11718758-B2 | Aqueous dispersion of colored particles | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2023-08-08 | — | — | US | disclosed |
| EP-3725854-B1 | COLORED PARTICLE AQUEOUS DISPERSION | MITSUBISHI PENCIL CO (JP) | 2023-07-05 | — | — | EP | disclosed |
| CN-111465662-B | Aqueous dispersion of coloured particles | 三菱铅笔株式会社 | 2023-05-26 | — | — | CN | disclosed |
| CN-108698824-B | Process for preparing polymeric sulfur | 伊士曼化工公司 | 2022-08-16 | — | — | CN | disclosed |
| WO-2021241484-A1 | WRITING IMPLEMENT | 三菱鉛筆株式会社 | 2021-12-02 | — | — | WO | disclosed |
| CN-108602965-B | Vulcanization composition containing cyclododecadithio and improved cyclododecylthio compound | 伊士曼化工公司 | 2021-11-12 | — | — | CN | disclosed |
| CN-108602965-B | Vulcanization composition containing cyclododecadithio and improved cyclododecylthio compound | 伊士曼化工公司 | 2021-11-12 | — | — | CN | disclosed |
| CN-113518757-A | Method useful for making cyclododecithio | 伊士曼化工公司 | 2021-10-19 | — | — | CN | disclosed |
| CN-113518759-A | Method useful for making cyclododecithio | 伊士曼化工公司 | 2021-10-19 | — | — | CN | disclosed |
| US-20010016269-A1 | FLUORESCENT MATERIALS AND THEIR USE | CIBA SPECIALTY CHEMICALS CORP. | 2001-08-23 | — | — | US | disclosed |
| US-6274065-B1 | COMPOSITION COMPRISING POLYMER MATRIX OR PRECURSOR, HOST CHROMOPHORE, PIGMENT PRECURSOR, WHEREIN ABSORPTION SPECTRUM OF PIGMENT (GUEST CHROMOPHORE), OBTAINED FROM PRECURSOR, OVERLAPS WITH FLUORESCENCE EMISSION SPECTRUM OF HOST CHROMPHORE | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-08-14 | — | — | US | disclosed |
| US-6080516-A | CONTAINING CHROMOPHORE | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-06-27 | — | — | US | disclosed |
| EP-0968254-A1 | FLUORESCENT MATERIALS AND THEIR USE | Ciba SC Holding AG (CH) | 2000-01-05 | — | — | EP | disclosed |
| EP-0963425-A1 | FLUORESCENT COMPOSITIONS AND THEIR USE | Ciba SC Holding AG (CH) | 1999-12-15 | — | — | EP | disclosed |
| EP-0963424-A1 | PROCESS FOR THE PREPARATION OF FLUORESCENT COMPOSITIONS, FLUORESCENT COMPOSITIONS AND THEIR USE | Ciba SC Holding AG (CH) | 1999-12-15 | — | — | EP | disclosed |
| WO-1998033862-A1 | FLUORESCENT MATERIALS AND THEIR USE | CIBA SPECIALITY CHEMICALS HOLDING INC. (CH) | 1998-08-06 | — | — | WO | disclosed |
| WO-1998033863-A1 | PROCESS FOR THE PREPARATION OF FLUORESCENT COMPOSITIONS, FLUORESCENT COMPOSITIONS AND THEIR USE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1998-08-06 | — | — | WO | disclosed |
| WO-1998033864-A1 | FLUORESCENT COMPOSITIONS AND THEIR USE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1998-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050027008-A1 | Cancer remedy comprising anthranilic acid derivatives as active ingredient | CA9, HCCS, CA7 | ALDH1A1 1389/4885HSD17B10 335/4885TP53 189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.